p-Bim BH3 (I155R, E158S)

General Information


DRACP ID  DRACP03055

Peptide Name   p-Bim BH3 (I155R, E158S)

Sequence  EIWIAQELRRRGDXFNAYYAR

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Induce apoptosis Bcl-xL/Bac-2 inhibitors BH3 peptides and mimetics



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Bcl-2/Bcl-xL

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  X=Phosphorylated-Ser

Chiral  L



Physicochemical Information


Formula  C114H169N35O30

Absent amino acids  CHKMPSTV

Common amino acids  R

Mass  297673

Pl  9.17

Basic residues  4

Acidic residues  3

Hydrophobic residues  8

Net charge  1

Boman Index  -6804

Hydrophobicity  -87.62

Aliphatic Index  70

Half Life 
  /

Extinction Coefficient cystines  8480

Absorbance 280nm  424

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26136077

Title  Conversion of cell-survival activity of Akt into apoptotic death of cancer cells by two mutations on the BIM BH3 domain

Doi 10.1038/cddis.2015.118

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.